SG Americas Securities
AQST icon

SG Americas Securities’s Aquestive Therapeutics AQST Stock Holding History

SG Americas Securities’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,090
Closed -$110K – 3206
2025
Q4 		$110K Buy
+17,090
New +$106K ﹤0.01% 3205
2025
Q3 		– Sell
-23,256
Closed -$77K – 3372
2025
Q2 		$77K Sell
23,256
-12,030
-34% -$34.5K ﹤0.01% 2683
2025
Q1 		$102K Buy
35,286
+2,320
+7% +$7.02K ﹤0.01% 3030
2024
Q4 		$117K Buy
32,966
+7,347
+29% +$33.9K ﹤0.01% 2611
2024
Q3 		$128K Buy
25,619
+9,496
+59% +$37K ﹤0.01% 2852
2024
Q2 		$42K Buy
16,123
+3,498
+28% +$11.7K ﹤0.01% 2703
2024
Q1 		$54K Buy
+12,625
New +$42K ﹤0.01% 2745
2020
Q3 		– Sell
-10,820
Closed -$53K – 2693
2020
Q2 		$53K Buy
+10,820
New +$49.8K ﹤0.01% 3522

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SG Americas Securities's AQST Position: Q1 2026 in Review

SG Americas Securities sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 17,090 shares — an estimated $110K sold.

SG Americas Securities first reported a position in AQST in Q2 2020 and held it in 8 quarters. The position peaked at $128K in Q3 2024. 180 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • SG Americas Securities reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 17,090 Aquestive Therapeutics shares in Q1 2026, an estimated $110K.
  • SG Americas Securities first reported a position in Aquestive Therapeutics in Q2 2020 and held it in 8 quarters.
  • SG Americas Securities's Aquestive Therapeutics position peaked at $128K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.